Erythrogran en es it fr

Erythrogran Brand names, Erythrogran Analogs

Erythrogran Brand Names Mixture

  • No information avaliable

Erythrogran Chemical_Formula

C9H13NO2

Erythrogran RX_link

No information avaliable

Erythrogran fda sheet

Erythrogran msds (material safety sheet)

Erythrogran Synthesis Reference

No information avaliable

Erythrogran Molecular Weight

167.205 g/mol

Erythrogran Melting Point

96 oC

Erythrogran H2O Solubility

2500 mg/L

Erythrogran State

Solid

Erythrogran LogP

1.514

Erythrogran Dosage Forms

No information avaliable

Erythrogran Indication

Used for the short-term treatment of insomnia, however, it generally has been replaced by other sedative-hypnotic agents.

Erythrogran Pharmacology

Ethinamate is used to treat insomnia (trouble in sleeping). However, it has generally been replaced by other medicines for the treatment of insomnia. If ethinamate is used regularly (for example, every day) to help produce sleep, it is usually not effective for more than 7 days. Structurally, it does not resemble the barbiturates, but it shares many effects with this class of drugs; the depressant effects of ethinamate are, however, generally milder than those of most barbiturates. Continued and inappropriate use of ethinamate can lead to tolerance and physical dependence, with withdrawal symptoms very similar to those of the barbiturates.

Erythrogran Absorption

Rapidly absorbed following oral administration.

Erythrogran side effects and Toxicity

Symptoms of overdose include shortness of breath or slow or troubled breathing, slow heartbeat, severe weakness, chronic confusion, slurred speech, and staggering.

Erythrogran Patient Information

Erythrogran Organisms Affected

Humans and other mammals